Protocol - Alkaline Phosphatase
Description
The National Health and Nutrition Examination Survey (NHANES) 2007-2008 Laboratory Procedure Manual documents the steps to draw the respondents blood, process and store the serum, and measure the concentration of alkaline phosphatase in international units per liter (IU/L ). The manual also includes information for safety precautions, quality control, and reference ranges for normal values.
Specific Instructions
The Skin, Bone, Muscle and Joint Working Group recommends obtaining a total plasma alkaline phosphatase level when the presence of Pagets disease is suspected.
There are many methods used to obtain alkaline phosphatase values. The 2007–2008 National Health and Nutrition Examination Survey (NHANES) used both the Beckman Synchron LX20 and Beckman UniCel® DxC800 Synchron, which yielded comparable results. Regardless of the method used, it is critical to know the reference ranges for that method so that the user can interpret the results of the bioassay.
Availability
Protocol
The following is a summary version of the full National Health and Nutrition Examination Survey (NHANES) 2007–2008 protocol.
Exclusion Criteria
Persons will be excluded from this component if they:
Report that they have hemophilia; or
Report that they have received cancer chemotherapy in the last 4 weeks
SP = Sample Person.
1. Do you have hemophilia?
1 [ ] Yes
2 [ ] No
7 [ ] Refused
9 [ ] Dont Know
If the SP answers, "Yes," the SP is excluded from the blood draw.
If SP answer "No" or "Dont Know," blood is drawn from the SP.
2. Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
1 [ ] Yes
2 [ ] No
7 [ ] Refused
9 [ ] Dont Know
If the SP answers, "Yes," the SP is excluded from the blood draw.
If SP answer "No" or "Dont Know," blood is drawn from the SP.
Note from the Skin, Bone, Muscle and Joint Working Group: The investigator should record the reason a person is excluded from the blood draw.
Venipuncture Procedures
Please review chapter 4 of the Laboratory Procedures Manual from the National Health and Nutrition Examination Survey 2007–2008 for a full description of phlebotomy procedures. 2007-2008 NHANES Lab Manual
Venipuncture should generally be performed using the median cubital, cephalic, or basilic veins in the left arm unless this arm is unsuitable. If the veins in the left arm are unsuitable, look for suitable veins on the right arm. If the veins in the antecubital space on both arms are not suitable, then look for veins in the forearm or dorsal side of the hand on the left arm/hand and then the right arm/hand.
Note from the Skin, Bone, Muscle and Joint Working Group: Blood should be collected in an appropriate 5-mL or 10-mL red-top tube or serum separator tube.
Recording the Results of the Venipuncture Procedure
Immediately after completing the venipuncture, record the results of the blood draw, the reasons for a tube not being drawn according to the protocol, and any comments about the venipuncture.
Blood Processing
Please review chapter 8 of the Laboratory Procedures Manual from the National Health and Nutrition Examination Survey 2007–2008 for a full description of blood processing procedures. 2007-2008 NHANES Lab Manual
Allow the blood to clot by setting aside for 30 to 45 minutes at room temperature. Do not clot for more than an hour.
Centrifuge the tube at room temperature to separate the serum and aliquot into an appropriate storage tube.
Determine whether the serum is hemolyzed, turbid, lipemic, or icteric. If so, enter a comment to describe the plasma.
Sample Storage
Note from the Skin, Bone, Muscle and Joint Working Group: Serum should be stored at -80C until testing and shipped on dry ice to prevent thawing.
Lab Assay for Serum Concentration of Alkaline Phosphatase
The Skin, Bone, Muscle and Joint Working Group recommends that alkaline phosphatase concentration be determined by a kinetic rate method. In this reaction, the concentration of the alkaline phosphatase is measured (in international units per liter; IU/L) by monitoring the ability of the enzyme to change a colorless organic phosphate substrate into a yellow colored product. The National Health and Nutrition Examination Survey 2007–2008 includes two examples of this method:
2007 –2008 NHANES Alkaline Phosphatase Lab Assay #1
2007–2008 NHANES Alkaline Phosphatase Lab Assay #2
Note from the Skin, Bone, Muscle and Joint Working Group: To aid comparability, the Working Group recommends that the investigator record the make and manufacturer of equipment used and the repeatability and coefficients of variation for the assay.
Reference Ranges for Alkaline Phosphatase*
Serum or Plasma | IU/L |
0–5 Y | 60–321 |
5–10 Y | 110–360 |
10–12 Y | 103–373 |
12–16 Y | 67–382 |
>16 Y | 36–113 |
* From the National Health and Nutrition Examination Survey 2007–2008 laboratory protocol.
Personnel and Training Required
Phlebotomist and a medical technologist or laboratory technician who is trained and found to be competent (i.e., tested by an expert) in the conduct of bioassays.
Equipment Needs
Laboratory capable of performing the kinetic rate method for determination of alkaline phosphatase activity.
Requirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Bioassay
Lifestage
Infant, Toddler, Child, Adolescent, Adult, Senior, Pregnancy
Participants
Lifespan (infants to older adults)
Selection Rationale
The National Health and Nutrition Examination Survey 2007–2008 manual was selected as the best standardized method for blood collection, sample processing and storage, and determination of alkaline phosphatase concentration.
Language
Chinese, English
Standards
Standard | Name | ID | Source |
---|---|---|---|
Logical Observation Identifiers Names and Codes (LOINC) | Alkaline phosphatase proto | 62898-2 | LOINC |
Human Phenotype Ontology | Abnormality of alkaline phosphatase activity | HP:0004379 | HPO |
Human Phenotype Ontology | Low alkaline phosphatase | HP:0003282 | HPO |
Human Phenotype Ontology | Elevated alkaline phosphatase | HP:0003155 | HPO |
caDSR Form | PhenX PX170101 - Alkaline Phosphatase | 6185868 | caDSR Form |
Derived Variables
None
Process and Review
Not applicable.
Protocol Name from Source
National Health and Nutrition Examination Survey Questionnaire (NHANES), Laboratory Procedures Manual, 2007
Source
Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). (2007). National Health and Nutrition Examination Survey Laboratory Procedure Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
General References
None
Protocol ID
170101
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping | |
---|---|---|---|---|
PX170101_Alkaline_Phosphatase_Concentration | ||||
PX170101090000 | Alkaline phosphatase concentration | N/A | ||
PX170101_Assay_Repeatability | ||||
PX170101070000 | Repeatability of the assay | N/A | ||
PX170101_Blood_Draw_Comments | ||||
PX170101040200 | Record any comments about the blood draw, more | Variable Mapping | ||
PX170101_Blood_Draw_Done | ||||
PX170101040000 | Was blood drawn? | Variable Mapping | ||
PX170101_Blood_Draw_Sample | ||||
PX170101040100 | Was full amount obtained? | N/A | ||
PX170101_Chemotherapy | ||||
PX170101020000 | Have you received cancer chemotherapy in the more | Variable Mapping | ||
PX170101_Coefficient_Of_Variation | ||||
PX170101080000 | Coefficient of variation for the assay | N/A | ||
PX170101_Equipment_Make | ||||
PX170101060100 | Make of the equipment used to perform the more | N/A | ||
PX170101_Equipment_Manufacturer | ||||
PX170101060200 | Manufacturer of the equipment used to more | N/A | ||
PX170101_Exclusion_Criteria | ||||
PX170101030000 | Exclusion Criteria | N/A | ||
PX170101_Hemophilia | ||||
PX170101010000 | Do you have hemophilia? (exclusion from more | Variable Mapping | ||
PX170101_Sample_Comments | ||||
PX170101050000 | Record any comments about the sample during more | Variable Mapping |
Measure Name
Alkaline Phosphatase
Release Date
November 12, 2010
Definition
This measure is a bioassay to determine the concentration of alkaline phosphatase in serum or plasma.
Purpose
This measure is used to determine the respondent's serum or plasma concentration of alkaline phosphatase in international units per liter (IU/L). An abnormal level of alkaline phosphatase is an indication of various conditions/diseases, such as liver and parathyroid disease. Alkaline phosphatase is also a marker of bone formation and as such is used to determine the presence of conditions that affect bone turnover, such as Paget's disease or vitamin D deficiency.
Keywords
alkaline phosphatase, Pagets disease, isoenzyme, liver disease, vitamin D deficiency, bone disease, bone formation, bone growth, parathyroid disease, bone, joint
Measure Protocols
Protocol ID | Protocol Name |
---|---|
170101 | Alkaline Phosphatase |
Publications
There are no publications listed for this protocol.